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Abstract
Background: In the absence of a systematic collection of data pertaining to heart failure, summarizing the data
available from individual studies provides an opportunity to estimate the burden of heart failure. The present study
systematically reviewed the literature to estimate the incidence and prevalence rates of heart failure in Australia.
Methods: Studies reporting on prevalence or incidence of heart failure published between 1990 and 2015 were
identified through a systematic search of Embase, PubMed, Ovid Medline, MeSH, Scopus and websites of the
Australian Institute of Health, and Welfare and Australian Bureau of Statistics.
Results: The search yielded a total of 4978 records, of which thirteen met the inclusion criteria. There were no studies
reporting on the incidence of heart failure. The prevalence of heart failure in the Australian population ranged between
1.0 % and 2.0 %, with a significant proportion of cases being previously undiagnosed. The burden of heart failure was
higher among Indigenous than non-Indigenous Australians (age-standardized prevalence rate ratio of 1.7). Heart failure
was prevalent in women than men, and in rural and remote regions than in the metropolitan and capital territories.
Conclusion: This systematic review highlights the limited available data on the epidemiology of heart failure in Australia.
Population level studies, using standardized approaches, are needed in order to precisely describe the burden of HF in
the population.
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Background
Heart failure (HF) causes a significant burden for patients
and healthcare systems in developed countries [1, 2].
Approximately 50–75 % of patients with HF die within
five years of diagnosis [3, 4]. Evidence shows that HF
accounts for 1–3 % of overall healthcare spending, mainly
due to repeated hospital admissions and prolonged in-
patient length of stay [1]. In developed countries, preva-
lence of HF ranges from 1–3 %, rising to 10 % or more in
those aged 75 years or older [1, 2], while estimates in
developing countries are not routinely reported.
The relationship between obesity, hypertension, smoking
and cholesterol with cardiovascular morbidity is undis-
puted. Australia has made significant attempts to address
risk factors contributing to the onset of chronic diseases
[5]. Public health policy on tobacco control, improvements
in surgical treatment and the widespread use of lipid and
blood pressure-lowering drugs have resulted in a signifi-
cant decline in the burden of major cardiovascular diseases
[5–8]. Despite these improvements, the burden of diabetes
and obesity in the population has steadily increased over
time [7].
Data on the incidence of HF is not reported in the
Australian Institute of Health and Welfare (AIHW)
periodic statistics [9], while the Australian National
Health Surveys (NHS) report prevalence rates based on
self-report [10]. However, self-reported data may
underestimate the true burden of HF because the early
stages of HF may be only mildly symptomatic; therefore
many people may be unaware that they have the condi-
tion [7]. Similarly, estimation based on mortality data
may under-report the actual burden of HF, as the inter-
national classification of diseases (ICD) recommends
coding underlying causes of death such as ischemic
heart diseases rather than HF, which is often the
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Variation in the definition of HF and process of estimation
therefore limit the validity and utility of data from these
sources [9, 10].
Despite the morbidity and economic burden to the
community and poor patient outcomes, there is a defi-
ciency in the systematic collection of data pertaining the
incidence and prevalence of HF. Therefore, summarizing
the data available from individual studies provides an
opportunity to estimate the burden of HF. The present
study systematically reviewed the literature to estimate the
incidence and prevalence rates of heart failure in Australia.
Methods
Literature search
The process of the review was designed and undertaken
according to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (Additional file 1) guidelines
[12]. We searched Embase, PubMed, Ovid Medline, MeSH,Studies included  
(n = 13) 
Full-text articles assessed 
for eligibility  
(n = 121) 
Records screened  
(n = 4105) 
Records after duplicates removed
(n = 4105) 
Records identified through database 
searching (n = 4969)  
Embase (n=421)                              
PubMed (n=4299)                          
Ovid Medline (n=171)               
MeSH (n=47)          
SCOPUS (n=31)
Fig. 1 PRISMA flow diagram of selection processand Scopus for articles published under subject terms:
heart failure, cardiac failure, congestive heart failure,
chronic heart failure, left ventricular dysfunction, sys-
tolic heart failure, diastolic heart failure combined with
epidemiology, incidence, prevalence, burden and mor-
bidity. The search was limited to articles published in
the Australian population in English, between September
1990 and 20 July 2015 (Additional file 2: Table S1). Rele-
vant studies on the prevalence and incidence of HF in
Australia were included. We further searched the AIHW
and Australian Bureau of Statistics (ABS) websites to iden-
tify relevant datasets and reports.
Study selection
Figure 1 summarises the selection process for the studies.
Publications retrieved from all databases were organized
in Endnote and duplicate publications were removed
(by BW). Two reviewers (BWS and MPM) independ-
ently reviewed abstracts and full text citations to screenAdditional records identified 
through hand-search   
(n = 9) 
Articles excluded (n = 108) 
1. Not primary study (6)      
2. Reporting different outcome 
(n=87)                    
3. Measured after medical 
conditions (n=2)      
4. Guidelines (N=4)            
5. Service delivery (N=8)
Records excluded (n =3984) 
1. Measured after medical 
conditions (n=3) 
2. Not primary study (n=363) 
3. From the same study (n=1) 
3. Reporting different outcome 
(n=3614) 
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to the selection of eligible publications. Studies were eli-
gible if: (1) reported on prevalence or incidence of HF in
Australia; (2) not clinical trials or therapeutic studies; (3)
and conducted on patients with pre-existing medical con-
ditions such as hypertension and coronary heart disease.Data extraction and summarisation
A summary table was prepared to ensure that all rele-
vant data including type of study, sample size, sampling
methods, age and sex of the participants, year of study,
scope of the study (national or single center), method of
diagnosis, and the primary outcomes (incidence and
prevalence rates) were extracted. Tables 1 and 2 provides
a summary of the studies included in the review. Due
to heterogeneity in data sources and design of the indi-
vidual studies, data were summarised narratively.Quality assessment
Quality of the studies selected for the review were
assessed using a checklist comprising the items recom-
mended by Sanderson et al. [13]. The items in the
checklist include: appropriate source population; meas-
urement methods; methods outlined to deal with any
design-specific issues such as recall bias, interviewer
bias, biased loss to follow or blinding; design and/or ana-
lytical methods; and appropriate use of statistics for pri-
mary analysis of effect. Each criterion was given a score
of zero or one, which was then summed in to summaryTable 1 Studies reporting prevalence of heart failure






Knox 2008 [17] 9156 of all ages, selected




Harrison 2013 [18] 8707 of all ages selected




NHS 2004/5 [14] National survey on ≥18 y National survey Self-r
NHS 2007/8 [15] National survey on ≥18 y National survey Self-r
NHS 2011/12 [16] National survey on ≥18 y National survey Self-r
NATSIHS 2008 [22] National survey on
≥18 y aboriginals
Survey Self-r
McGrady 2012 [21] 436 random sample
>18 yrs
Cross sectional Echo
Clark 2004 [26] No mentioned Cross sectional adm
Clark 2005 [23] No mentioned Cross sectional adm
Clark 2007 [20] 23845, ≥60 yrs selected
from 341 general practice
Cross sectional WHO
CHF congestive heart failure, GP general practice, NHS national health survey, WHO
islander health survey, Echo echocardiographyscore (0 to 5). The score for each article was an average
value of the score assigned by two independent reviewers
(BWS and DM Emdadul Hoque). The studies selected for
the review had an overall quality score of three or more
out of five. This study used publicly available data which
does not require ethical approval.Results
Description of studies
The search yielded 4978 citations. After screening the
titles and abstracts and removing duplicates, 121 studies
remained for the full text review. Thirteen studies which
met the inclusion criteria were selected (Tables 1 and 2).
Ten were cross-sectional studies [14–23], and three studies
extrapolated data from other countries to the Australian
population [24–26].Participants and method of diagnosis
Six studies recruited participants from the community [14–
16, 19, 21, 22] three from clinical settings [17, 18, 20] and
the remainder used administrative data [14, 23, 25, 26]. Five
studies were conducted in adults (≥18 years) [14–16,
22], two in those 60 years or over [19, 20], two in all
age groups [17, 18], with participant’s age not speci-
fied in the reminder [23–26]. Heart failure was defined
based self-report [14–16, 22], echocardiography (and
physical assessment) [19, 21], using modified World
Health Organization criteria [20] while the rest used ad-
ministrative data [17, 18, 23, 25, 26] (Tables 1 and 2).Prevalence (%)
od of diagnosis Male Female Total Quality rating
ical examination, and Echo 8.2 4.4 6.3 4
ical record - - 1.8 4.1
ical record - - 1.5 4
eport 0.9 1.8 1.4 3
eport 1.0 1.7 1.3 3
eport 1.0 1.5 1.2 3
eport 1.74 2.88 1.0
7 4 5.3 4.3
inistrative data - - 2.0 3.0
inistrative data - - 1.8 3.3
criteria - - 13.1 3.5
World Health Organization, NATSIHS national aboriginal and torres strait
Table 2 Studies reporting prevalence of heart failure by geographic locations
Author Sample size Geographic stratum (%) Quality rating
Clark 2004 [26] Not mentioned Central and west Australia (28.8–79.9 per 1000) 3.2
Queensland, New South Wales, Western Australia (20.3–28.7 per 1000)
Clark 2005 [23] Not mentioned Australian Capital Territory (14 per 1000) 3.3
Northern Territory (29.5 per 1000)
McGrady 2012 436 random sample >18 yrs Urban (6 %) Remote (4 %) 4.3
Clark 2007 [20] 23845, ≥60 yrs selected from 341 GP center Capital cities and metropolitan (12.4 %) 3.5
Large and small rural towns (16.1 %)
Other rural and remote areas (13.9 %)
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There were no studies reporting the incidence of HF in
Australia. According to the AHIW (based up on extrapo-
lation of incidence rates from large scale international
cohorts to the Australian population characteristics) an
estimated 30,000 new cases of HF are diagnosed each year
in Australia [24], which translates in to a crude incidence
rate of 2.1 per 1000 population.Prevalence of heart failure
Prevalence of HF was reported in twelve studies
[14–23, 25, 26]. Based on self-report, the prevalence
of HF and oedema in adults was estimated to be
1.4 % in the 2004/5, 1.3 % in the 2007/8, and 1.2 %
in the 2011/12 National Health Surveyes [14–16].
The national population prevalence of HF was reported
in four studies, ranging from 1.5–2.0 % [17, 18, 20, 26].
Two studies reported the prevalence of chronic condi-
tions among a sample of 9156 [17] and 8707 [18] gen-
eral practice patients adjusted for the Australian
population. In these studies the prevalence of HF in
the population was estimated to be 1.8 % [17] and
1.5 % [18], respectively. In the third study, HF data
were derived by applying international HF prevalence
data to the Australian population [25]. The study re-
ported a national prevalence of 17.9 per 1000 [25].
Slightly higher prevalence rate (2.0 %) was also re-
ported in a similar study, which extrapolated HF data
from Scotland and United Kingdom to the Australian
popaultion [26].
In the Canberra Heart Study, which screened 1275
people aged 60–86 years old, 6.7 % (95 % CI: 4.4 %-
7.1 %) of them had HF and 0.6 % (95 % CI: 0.3 %-1.2 %)
of these were previously undiagnosed [19]. In the same
study, the prevalence of HF ranged between 3.1 % in
those 60–64 years old to 13.6 % in those 80–86 years
old [19]. In another study on a sample of 23845 gen-
eral practice patients aged 60 years and over, HF was
reported in 13.1 % of them comprising previously diag-
nosed cases (prevalence, 11.2 %) and newly diagnosed cases(prevalence, 1.9 %) [20] However, this rate was not ad-
justed for the general population.
In a study that screened 436 indigenous adults
(18 years or over), HF was diagnosed in 5.3 % of them,
of which 65 % were previously undiagnosed [21]. In the
2004/5 National Aboriginal and Torres Strait Islander
Health Survey (NATSIHS) [22] the prevalence of HF
among Indigenous Australians was 1.0 %. However,
following age-standardization the prevalence of HF
was 1.7 times higher among Indigenous than non-
Indigenous Australians [22].Heart failure by gender
In the NHS [14–16, 22] HF was almost twice common
in women than in men. Prevalence rates were 0.89 % vs
1.8 % in the 2004/5 NHS, 1.0 % vs 1.7 % in the NHS
2007/8 and 1.0 % vs 1.5 % in the NHS 2011/12 in men
and women, respectively [14–16]. Similarly, in the 2004/
5 NATSIHS, the age-standardized prevalence of HF was
17.4 per 1000 in men and 28.8 per 1000 in women [22].
On the other hand, In the Canberra Heart Study, HF was
twice as common in men (8.2 %) than in women (4.4 %)
[19]. Similarly, the prevalence of HF was 7.0 % in male
and 4.0 % in female adult Indigenous Australians [21].Heart failure by geographic location
Four studies reported on HF by geographic location
[20, 21, 23, 25]. Clark and colleagues reported a higher
prevalence of HF in large and small rural towns
(16.1 %) than in the capital city and metropolitan areas
(12.4 %) [20]. In the second study, prevalence rates
ranged between 2.9 % and 7.8 % in Central and Western
Australia and between 2.0 % and 2.9 % in parts of
Queensland, New South Wales, and Western Australia
[23]. The prevalence of HF also varied from 14 per
1000 in the Australian Capital Territory compared to
29 per 1000 in rural Northern Territory [25]. McGrady
and colleagues also reported higher in prevalence of HF
in urban Aboriginals (6.0 %) than those in remote com-
munities (4.0 %) [21].
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Our findings indicate that the prevalence of HF in the
Australian population ranges from 1.0–2.0 %, and varies
by Indigenous status, gender, age, and geographic loca-
tion. The burden of HF was higher among Indigenous
than non-Indigenous Australians, and in rural and remote
than in capital city and metropolitan areas. In most of the
studies reviewed, HF was more prevalent in women than
in men.
As indicated in the AIHW reports, there are no studies
reporting on the incidence of HF. [7] The only data avail-
able was the number of new cases of HF diagnosed each
year, estimated based on overseas data, which may not be
generalizable to the population due to limitations inherent
to the process of extrapolation [24].
Our findings of the prevalence of HF in Australia
(1.0–2.0 %) is congruent with data from Europe and
North America where prevalence of HF range between
1.3 % and 2.2 % [1, 27–29]. Consistent with existing
knowledge [30, 31] HF was three or more times higher
in the elderly than in the population. In general, the
NHS [14–16] reported a lower prevalence of HF com-
pared with the individual studies [17, 18, 20, 26] which
may be related to the use of self-reported diagnosis in
the NHS [7]. The significant proportion of previously
undiagnosed HF patients [19, 21] also reveal a chance
of underestimation when HF is defined based on self-
reported diagnosis.
In most of the studies [14–16, 22] HF was twice more
prevalent in women than men, although men were more
affected than women in two other studies [19, 21]. The
inconsistency in the prevalence of HF by gender has
been reported in several studies [3, 32, 33]. In Australia,
major risk factors of HF including coronary heart
diseases, diabetes, and high blood pressure are higher in
men than in women [7, 34]. However, risk factors of HF
such as diabetes, hypertension, and left ventricular dys-
function have stronger risk of progression to HF in
women than men, which may explain the higher preva-
lence of HF among women [30, 35]. The higher burden
of HF among women could be also be attributed to the
longer life expectancy and higher incidence of HF in
later years of life in women than men [36].
The higher prevalence of HF among Indigenous
Australians is consistent with the existing literature.
The latest Australian statistics shows that cardiovascular
diseases are 1.3 times more common among Indigenous
than their non-Indigenous counterparts [8]. The excess
burden of HF, cardiovascular diseases in general, in
Indigenous population is related to the overall disparity
in the social and economic status that impact on their
health status [22]. The risk factors of HF are also re-
ported to be more prevalent among Indigenous popula-
tion than the nationally reported data [21].According to previous studies [22, 25] the dispropor-
tionately higher burden of HF in rural and remote towns
is related to the concentration of older age inhabitants
and higher prevalence of socio-demographic risk factors
in these regions. Indigenous Australians, who have
higher prevalence of HF also concentrate in rural and re-
mote towns [25]. The comparatively lower access to
healthcare services in rural and remote regions, which
may affect early identification and management of the
risk factors predisposing to HF, could also contribute to
the geographic disparity [20, 23, 25].
The syndrome of HF has different causes and diverse
clinical presentations, and long-term clinical evolution
that makes its diagnosis challenging [1, 37]. Studies
based on self-reported diagnosis are likely to underesti-
mate the burden of HF because participants may not
know their HF status [37, 38]. Limitations inherent to
use of administrative data such misclassification may
also compromise the validity of HF data from such studies.
Therefore the overall estimate of the burden of HF is likely
to be affected by the use of different definitions and
measurement methods for HF.
This systematic review has some limitations. There
were limited studies on epidemiology of HF in
Australia and therefore studies that used varying HF
definition (such as heart failure and oedema) were in-
cluded in the review. Due to the limited number of
studies, further description of the pattern of HF over
time was not possible. Moreover, the search was re-
stricted to PubMed indexed journals, and unpublished
reports. As a result, articles published non-PubMed
indexed journals may have been missed. Despite these
limitations, the current review still provides valuable
information on the prevalence of HF in the Australian
population. Extensive and systematic literature search
using pre-defined quality assessment and inclusion
criteria were employed.
Conclusions
This review shows that the prevalence heart failure in
Australia is similar to other developed countries, however
it has a significant burden in specific demographic profiles
in the country, namely Indigenous groups, females and
those who reside in rural and remote areas. Further
population-level studies, with clearly defined method of
diagnosis, are needed for a more accurate description
of the burden of HF in Australia.
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